Characterization of HKI-272 Covalent Binding to Human Serum Albumin

作者: Jianyao Wang , Xiao Xian Li-Chan , Jim Atherton , Lin Deng , Robert Espina

DOI: 10.1124/DMD.110.032292

关键词:

摘要: The study was initiated as an observation of incomplete extraction recovery N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide (HKI-272) from human plasma. objective this to 1) identify the binding site(s) HKI-272 plasma protein(s); 2) characterize nature binding; and 3) evaluate potential reversibility covalent binding. After incubation [(14)C]HKI-272 with plasma, mixture directly injected on liquid chromatography/mass spectrometry (LC/MS), intact molecular mass serum albumin (HSA) adduct determined be 66,999 Da, which is 556 Da (molecular HKI-272) larger than measured HSA (66,443 Da). For peptide mapping, separated SDS-polyacrylamide gel electrophoresis followed by tryptic digestion combined LC/tandem MS. A radioactive fragment, LDELRDEGKASSAK [amino acid (AA) residue 182-195 albumin], confirmed covalently bind HKI-272. In addition, after HCl hydrolysis, a HKI-272-lysine identified LC/MS. combining results AA Lys190 standard synthesized characterized NMR. data showed that formed via Michael addition epsilon-amine lysine attacking beta-carbon amide moiety Furthermore, shown when gradual release observed protein pellet HKI-272-treated resuspension in phosphate buffer, pH 7.4, at 37 degrees C for 18 h.

参考文章(26)
D J Birkett, G Sudlow, D N Wade, The characterization of two specific drug binding sites on human serum albumin. Molecular Pharmacology. ,vol. 11, pp. 824- 832 ,(1975)
Carlo Bertucci, Enrico Domenici, Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance Current Medicinal Chemistry. ,vol. 9, pp. 1463- 1481 ,(2002) , 10.2174/0929867023369673
L Z Benet, A L Burlingame, Y Qiu, Mechanisms for Covalent Binding of Benoxaprofen Glucuronide to Human Serum Albumin: Studies by Tandem Mass Spectrometry Drug Metabolism and Disposition. ,vol. 26, pp. 246- 256 ,(1998)
Thomas A. Baillie, J. Greg Slatter, Glutathione: a vehicle for the transport of chemically reactive metabolites in vivo Accounts of Chemical Research. ,vol. 24, pp. 264- 270 ,(1991) , 10.1021/AR00009A003
A. Van Schanke, P. J. Van Bladeren, B. Van Ommen, J. H. T. M. Ploemen, Reversible Conjugation of Ethacrynic Acid with Glutathione and Human Glutathione S-Transferase P1-1 Cancer Research. ,vol. 54, pp. 915- 919 ,(1994)
Alexander Makarov, Electrostatic Axially Harmonic Orbital Trapping: A High-Performance Technique of Mass Analysis Analytical Chemistry. ,vol. 72, pp. 1156- 1162 ,(2000) , 10.1021/AC991131P
Lawrence M. Sayre, De Lin, Quan Yuan, Xiaochun Zhu, Xiaoxia Tang, Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metabolism Reviews. ,vol. 38, pp. 651- 675 ,(2006) , 10.1080/03602530600959508
Naila Ahmed, Darin Dobler, Mark Dean, Paul J Thornalley, None, Peptide Mapping Identifies Hotspot Site of Modification in Human Serum Albumin by Methylglyoxal Involved in Ligand Binding and Esterase Activity Journal of Biological Chemistry. ,vol. 280, pp. 5724- 5732 ,(2005) , 10.1074/JBC.M410973200
Allan Wissner, Heidi L. Fraser, Charles L. Ingalls, Russell G. Dushin, M. Brawner Floyd, Kinwang Cheung, Thomas Nittoli, Malini R. Ravi, Xingzhi Tan, Frank Loganzo, Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2. Bioorganic & Medicinal Chemistry. ,vol. 15, pp. 3635- 3648 ,(2007) , 10.1016/J.BMC.2007.03.055